BioCryst Pharmaceuticals
BCRX
#4483
Rank
โ‚ฌ2.02 B
Marketcap
8,08ย โ‚ฌ
Share price
1.15%
Change (1 day)
30.10%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): โ‚ฌ0.22 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.87 Billion. , an increase over its 2024 earnings that were of -โ‚ฌ73.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ0.22 B-407.51%
2024 -โ‚ฌ73.74 Million-61.56%
2023 -โ‚ฌ0.2 Billion-7.43%
2022 -โ‚ฌ0.21 Billion34.42%
2021 -โ‚ฌ0.16 Billion-0.55%
2020 -โ‚ฌ0.16 Billion67.88%
2019 -โ‚ฌ92.35 Million7.55%
2018 -โ‚ฌ85.87 Million53.92%
2017 -โ‚ฌ55.79 Million19.29%
2016 -โ‚ฌ46.77 Million28.19%
2015 -โ‚ฌ36.49 Million-4.8%
2014 -โ‚ฌ38.33 Million50.09%
2013 -โ‚ฌ25.54 Million-23.29%
2012 -โ‚ฌ33.29 Million-26.19%
2011 -โ‚ฌ45.1 Million54.78%
2010 -โ‚ฌ29.14 Million150.1%
2009 -โ‚ฌ11.65 Million-49.43%
2008 -โ‚ฌ23.04 Million14.07%
2007 -โ‚ฌ20.2 Million-49.31%
2006 -โ‚ฌ39.84 Million72.87%
2005 -โ‚ฌ23.05 Million22.08%
2004 -โ‚ฌ18.88 Million75.3%
2003 -โ‚ฌ10.77 Million-25.36%
2002 -โ‚ฌ14.43 Million225.05%
2001 -โ‚ฌ4.44 Million-56.6%
2000 -โ‚ฌ10.23 Million50.63%
1999 -โ‚ฌ6.79 Million38.05%
1998 -โ‚ฌ4.92 Million-52.46%
1997 -โ‚ฌ10.35 Million58.44%
1996 -โ‚ฌ6.53 Million-14.44%
1995 -โ‚ฌ7.64 Million28.57%
1994 -โ‚ฌ5.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚ฌ8.30 B 3,563.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ8.39 B 3,600.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚ฌ0.22 Billion-194.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ71.14 M-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ0.31 B 40.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.25 Billion-207.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚ฌ6.9 Million-103.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚ฌ21 Million-109.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-38.18%๐Ÿ‡บ๐Ÿ‡ธ USA